Abstract
It is now well-established that human papillomavirus (HPV)-associated squamous cell carcinoma, which comprises an increasing proportion of all oropharyngeal cancers, represents a unique entity with distinct clinical and molecular characteristics. Data also has emerged demonstrating that patients with HPVpositive head and neck cancer have an improved prognosis compared to their HPV-negative counterparts, with several series showing that patients with HPV-related tumors arising from the oropharynx have at least half the risk of death. However, these studies have been complicated by such factors as the limited quality of data, small sample sizes, as well as the variability in treatment, inclusion criteria, and follow-up. Although the exact reason for the improved survival among HPV-positive patients is unclear, many investigators have proposed that HPV-related head and neck cancer is more sensitive to the effects of radiation therapy than HPVnegative tumors arising in the setting of traditional environmental exposures. Despite the attractiveness of this hypothesis, the data focusing on possible de-intensification approaches remains preliminary, and treatment paradigms will likely continue to evolve as findings from innovative clinical trials yield answers to many provocative questions.
Keywords: Cancer, head and neck, HPV, radiation, squamous cell.
Current Cancer Therapy Reviews
Title:Evolving Treatment Paradigms for HPV-Related Oropharynx Cancer
Volume: 10 Issue: 4
Author(s): Allen M. Chen, Deborah Wong and Maie St. John
Affiliation:
Keywords: Cancer, head and neck, HPV, radiation, squamous cell.
Abstract: It is now well-established that human papillomavirus (HPV)-associated squamous cell carcinoma, which comprises an increasing proportion of all oropharyngeal cancers, represents a unique entity with distinct clinical and molecular characteristics. Data also has emerged demonstrating that patients with HPVpositive head and neck cancer have an improved prognosis compared to their HPV-negative counterparts, with several series showing that patients with HPV-related tumors arising from the oropharynx have at least half the risk of death. However, these studies have been complicated by such factors as the limited quality of data, small sample sizes, as well as the variability in treatment, inclusion criteria, and follow-up. Although the exact reason for the improved survival among HPV-positive patients is unclear, many investigators have proposed that HPV-related head and neck cancer is more sensitive to the effects of radiation therapy than HPVnegative tumors arising in the setting of traditional environmental exposures. Despite the attractiveness of this hypothesis, the data focusing on possible de-intensification approaches remains preliminary, and treatment paradigms will likely continue to evolve as findings from innovative clinical trials yield answers to many provocative questions.
Export Options
About this article
Cite this article as:
M. Chen Allen, Wong Deborah and St. John Maie, Evolving Treatment Paradigms for HPV-Related Oropharynx Cancer, Current Cancer Therapy Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/157339471004150407140835
DOI https://dx.doi.org/10.2174/157339471004150407140835 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions
Current Medicinal Chemistry Anal Carcinoma
Current Cancer Therapy Reviews Ribonucleotide Reductase: A Critical Enzyme for Cancer Chemotherapy and Antiviral Agents
Recent Patents on Anti-Cancer Drug Discovery Preclinical and Clinical Studies of Novel Breast Cancer Drugs Targeting Molecules Involved in Protein Kinase C Signaling, the Putative Metastasis-Suppressor Gene Cap43 and the Y-box Binding Protein-1
Current Medicinal Chemistry Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
Current Cancer Drug Targets PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
Current Medicinal Chemistry Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
Current Pharmaceutical Design Applications of HPLC-MALDI-TOF MS/MS Phosphoproteomic Analysis in Oncological Clinical Diagnostics
Current Proteomics Ischiofemoral Impingement Syndrome: Effect of Morphological Variations on the Diagnosis
Current Medical Imaging Acyclonucleosides, Modified Seco-Nucleosides, and Salicyl- or Catechol- Derived Acyclic 5-Fluorouracil O,N-Acetals: Antiproliferative Activities, Cellular Differentiation and Apoptosis
Current Medicinal Chemistry Angiotensin-Converting Enzymes (ACE and ACE2) as Potential Targets for Malignant Epithelial Neoplasia: Review and Bioinformatics Analyses Focused in Oral Squamous Cell Carcinoma
Protein & Peptide Letters Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Heat Shock Protein 70s as Potential Molecular Targets for Colon Cancer Therapeutics
Current Medicinal Chemistry Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Tumor-Associated Macrophages as Potential Targets for Anti-Cancer Activity of Marine Invertebrate-Derived Compounds
Current Pharmaceutical Design Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs Involved in Oxidative Stress Processes Regulating Physiological and Pathological Responses
MicroRNA KRAS: A Promising Therapeutic Target for Cancer Treatment
Current Topics in Medicinal Chemistry Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Current Pharmaceutical Design Glucose-6-phosphate Dehydrogenase: a Biomarker and Potential Therapeutic Target for Cancer
Anti-Cancer Agents in Medicinal Chemistry